Related Experiment Video
Updated: Mar 14, 2026

04:08
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
Published on: June 27, 2025
1.3K
Placental implantation abnormalities: a modern approach
Sevan A Vahanian1, Anthony M Vintzileos
1aDepartment of Obstetrics and Gynecology, Winthrop University Hospital, Mineola, New York bDepartment of Obstetrics, Gynecology, and Reproductive Medicine, Stony Brook University School of Medicine, Stony Brook, New York, USA.
Current Opinion in Obstetrics & Gynecology
|September 24, 2016
Summary
Placental implantation abnormalities (PIAs) increase risks for mothers and babies. Early diagnosis via ultrasound and MRI, alongside individualized management, is crucial for improving outcomes and reducing prematurity risks.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Diagnostic Imaging
Background:
- Placental implantation abnormalities (PIAs) are linked to severe maternal, fetal, and neonatal complications.
- Prior uterine surgery and placenta previa are established risk factors, with recent evidence highlighting prior cesarean delivery and postpartum hemorrhage.
Purpose of the Study:
- To review recent findings and current understanding of placental implantation abnormalities.
- To discuss diagnostic methods and management strategies for PIAs.
Main Methods:
- Review of recent literature on placental implantation abnormalities.
- Discussion of diagnostic modalities including ultrasound (transvaginal, color Doppler) and MRI.
- Analysis of risk factors, diagnostic findings, and proposed management strategies.
Main Results:
- PIAs are a significant cause of preterm birth, with prematurity rates from 38-82%.
- Diagnostic tools like ultrasound and MRI reveal specific features indicative of PIAs, including cesarean scar pregnancy in the first trimester.
- Delivery recommendations are preterm and based on expert opinion, with management strategies tailored to cervical length and placental characteristics.
Conclusions:
- Individualized management strategies are emerging to optimize delivery timing and mitigate prematurity risks.
- Further large-scale prospective studies or randomized trials are needed to validate the benefits of individualized care for PIAs.

